Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (428)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
60
2026
2393
6.090
 Why?
Receptors, Estrogen
24
2026
404
3.140
 Why?
Estrogen Receptor alpha
6
2025
151
1.490
 Why?
Receptors, Progesterone
13
2025
244
1.460
 Why?
Brain Neoplasms
16
2026
1331
1.120
 Why?
Estradiol
4
2025
515
1.000
 Why?
Aging, Premature
1
2025
17
0.910
 Why?
High-Intensity Interval Training
1
2025
45
0.870
 Why?
Doxorubicin
4
2025
403
0.850
 Why?
Antibiotics, Antineoplastic
1
2025
140
0.840
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2025
1969
0.800
 Why?
Estrogens
8
2026
367
0.800
 Why?
Keratin-5
6
2022
44
0.790
 Why?
Triple Negative Breast Neoplasms
6
2023
218
0.750
 Why?
Breast Neoplasms, Male
3
2018
29
0.730
 Why?
Biomarkers, Tumor
7
2022
1329
0.700
 Why?
Stem Cells
8
2006
630
0.700
 Why?
Tetrahydronaphthalenes
1
2021
34
0.650
 Why?
Chromatin
1
2025
553
0.650
 Why?
Antineoplastic Agents, Hormonal
7
2025
196
0.650
 Why?
MCF-7 Cells
5
2025
133
0.640
 Why?
Neoplasm Metastasis
4
2020
688
0.630
 Why?
Immunoprecipitation
4
2020
149
0.630
 Why?
Drug Resistance, Neoplasm
5
2025
883
0.610
 Why?
Neoplastic Cells, Circulating
1
2020
81
0.610
 Why?
Neurons
9
2026
1652
0.610
 Why?
Brain Edema
2
2023
62
0.600
 Why?
Benzodiazepines
1
2021
168
0.590
 Why?
Female
62
2026
79035
0.570
 Why?
Radiosurgery
3
2023
399
0.570
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
61
0.560
 Why?
Epithelial-Mesenchymal Transition
1
2020
220
0.550
 Why?
Leukocytes, Mononuclear
2
2020
574
0.550
 Why?
Artifacts
2
2016
143
0.550
 Why?
Binding Sites
2
2025
1311
0.550
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1450
0.520
 Why?
Gene Expression Profiling
7
2020
1777
0.520
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
4
0.510
 Why?
Polyadenylation
1
2017
39
0.510
 Why?
High-Throughput Nucleotide Sequencing
4
2019
534
0.500
 Why?
Protein Kinase Inhibitors
7
2025
981
0.500
 Why?
Neoplastic Stem Cells
7
2020
409
0.500
 Why?
Organoplatinum Compounds
1
2016
65
0.490
 Why?
Carcinogenesis
2
2020
228
0.490
 Why?
Cancer-Associated Fibroblasts
1
2016
23
0.490
 Why?
Piperazines
5
2025
375
0.470
 Why?
Humans
75
2026
145763
0.460
 Why?
Cell Line, Tumor
17
2026
3551
0.460
 Why?
Pyridines
6
2025
609
0.460
 Why?
Fluorouracil
1
2016
231
0.460
 Why?
CD146 Antigen
3
2021
38
0.450
 Why?
Mitochondrial Proteins
1
2017
263
0.440
 Why?
Microscopy, Electron, Scanning Transmission
1
2014
3
0.440
 Why?
Thrombocytopenia
1
2016
204
0.430
 Why?
Microwaves
1
2014
28
0.420
 Why?
Maytansine
1
2014
18
0.420
 Why?
Microscopy
1
2014
147
0.390
 Why?
Trastuzumab
5
2023
118
0.370
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
209
0.370
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2026
58
0.370
 Why?
Progestins
6
2025
66
0.360
 Why?
Neoplasms, Hormone-Dependent
1
2012
33
0.360
 Why?
Tamoxifen
5
2025
193
0.360
 Why?
RNA-Binding Proteins
1
2016
447
0.360
 Why?
Antineoplastic Agents
4
2023
2219
0.350
 Why?
Analgesics, Opioid
1
2021
1154
0.350
 Why?
Tumor Microenvironment
4
2021
735
0.350
 Why?
RNA Polymerase III
2
2025
34
0.350
 Why?
Homeodomain Proteins
5
2018
523
0.350
 Why?
MicroRNAs
5
2016
686
0.350
 Why?
RNA
2
2016
912
0.330
 Why?
Chemotherapy, Adjuvant
5
2023
427
0.330
 Why?
Repressor Proteins
2
2025
429
0.330
 Why?
Cancer Survivors
2
2026
338
0.320
 Why?
Neoplasm Recurrence, Local
5
2021
1150
0.320
 Why?
Mutation
3
2021
4090
0.320
 Why?
Image Processing, Computer-Assisted
1
2014
782
0.310
 Why?
Neoadjuvant Therapy
3
2021
467
0.310
 Why?
Antibodies, Monoclonal, Humanized
2
2021
992
0.300
 Why?
Tumor Cells, Cultured
7
2020
887
0.290
 Why?
Astrocytes
6
2026
228
0.290
 Why?
Pyrimidines
3
2018
530
0.290
 Why?
Liver Neoplasms
1
2015
777
0.280
 Why?
Middle Aged
20
2026
36302
0.280
 Why?
Neoplasm Staging
5
2026
1474
0.280
 Why?
Carcinoma, Ductal, Breast
2
2020
90
0.280
 Why?
Hydrocephalus
3
2023
111
0.280
 Why?
Signal Transduction
6
2026
5223
0.280
 Why?
Colorectal Neoplasms
1
2016
868
0.280
 Why?
Prognosis
7
2021
4329
0.270
 Why?
Adenocarcinoma
1
2015
926
0.270
 Why?
Bone Marrow Cells
2
2014
322
0.260
 Why?
Aged
17
2025
26215
0.240
 Why?
Neural Cell Adhesion Molecules
1
2026
38
0.240
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.240
 Why?
Adult
20
2026
40872
0.230
 Why?
Necrosis
2
2019
244
0.230
 Why?
Fibroblast Growth Factor 2
1
2026
94
0.230
 Why?
Aged, 80 and over
7
2025
8346
0.230
 Why?
Cluster Analysis
4
2019
501
0.230
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.230
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.220
 Why?
Sequence Analysis, RNA
2
2019
442
0.220
 Why?
Protein Binding
2
2025
2240
0.220
 Why?
STAT1 Transcription Factor
1
2025
66
0.220
 Why?
Neuroglia
2
2003
174
0.220
 Why?
Neoplasm Grading
2
2017
311
0.210
 Why?
Weight Reduction Programs
1
2026
140
0.210
 Why?
RNA, Transfer
1
2025
143
0.210
 Why?
Mice, Inbred NOD
5
2021
616
0.210
 Why?
Genetic Therapy
2
2003
316
0.210
 Why?
Animals
28
2026
38097
0.200
 Why?
Aminopyridines
2
2025
129
0.200
 Why?
Carbolines
1
2024
35
0.200
 Why?
Disease-Free Survival
4
2024
770
0.200
 Why?
Triazines
1
2024
49
0.200
 Why?
Aromatase Inhibitors
2
2021
81
0.200
 Why?
Progesterone
3
2014
215
0.200
 Why?
Mice
20
2026
18355
0.200
 Why?
Benzimidazoles
2
2025
189
0.200
 Why?
Obesity
3
2026
3118
0.200
 Why?
Morpholines
1
2024
130
0.190
 Why?
Promoter Regions, Genetic
3
2025
1247
0.190
 Why?
Extracellular Matrix Proteins
1
2004
156
0.190
 Why?
Keratin-17
1
2022
4
0.190
 Why?
Aquaporin 4
2
2023
101
0.180
 Why?
Triglycerides
1
2025
520
0.180
 Why?
Nerve Regeneration
1
2002
58
0.180
 Why?
Mice, SCID
4
2020
369
0.180
 Why?
Stromal Cells
2
2020
121
0.180
 Why?
Down-Regulation
4
2015
618
0.180
 Why?
Tumor Suppressor Proteins
2
2015
322
0.180
 Why?
Glioma
5
2006
429
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2025
108
0.180
 Why?
Cell-Free Nucleic Acids
1
2022
34
0.180
 Why?
Immunoconjugates
1
2023
138
0.180
 Why?
Neoplasm Invasiveness
3
2020
508
0.170
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.170
 Why?
Cyclins
1
2002
79
0.170
 Why?
Transcription, Genetic
2
2025
1454
0.170
 Why?
Lipid Metabolism
1
2025
529
0.170
 Why?
Tumor Suppressor Protein p53
2
2015
534
0.170
 Why?
Overweight
1
2026
614
0.170
 Why?
Medicare
3
2023
904
0.170
 Why?
Insulin Receptor Substrate Proteins
1
2020
55
0.160
 Why?
Brain
3
2026
2969
0.160
 Why?
Gene Regulatory Networks
2
2014
318
0.160
 Why?
Cell Adhesion Molecules
1
2021
181
0.160
 Why?
Disease Progression
5
2026
2865
0.160
 Why?
gamma-Aminobutyric Acid
1
2002
194
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Meningeal Carcinomatosis
1
2020
7
0.160
 Why?
RNA, Messenger
3
2019
2805
0.150
 Why?
Antigens, Neoplasm
1
2021
271
0.150
 Why?
Hyaluronan Receptors
4
2014
104
0.150
 Why?
Cell Proliferation
6
2025
2514
0.150
 Why?
Retrospective Studies
6
2025
17325
0.150
 Why?
SEER Program
1
2021
230
0.150
 Why?
Gene Library
2
2019
122
0.150
 Why?
Antineoplastic Agents, Immunological
2
2019
198
0.150
 Why?
Carcinoma, Lobular
1
2020
56
0.150
 Why?
Transcriptome
2
2019
1042
0.150
 Why?
Collagen
2
2020
457
0.150
 Why?
Lymphatic Metastasis
2
2017
336
0.140
 Why?
ErbB Receptors
2
2020
635
0.140
 Why?
Treatment Outcome
6
2025
11793
0.140
 Why?
Paclitaxel
1
2020
259
0.140
 Why?
beta Catenin
1
2020
254
0.130
 Why?
Heterografts
4
2020
143
0.130
 Why?
Xenograft Model Antitumor Assays
4
2017
936
0.130
 Why?
3' Untranslated Regions
1
2017
149
0.120
 Why?
Feasibility Studies
2
2026
1115
0.120
 Why?
Pyrroles
1
2017
220
0.120
 Why?
Quinolines
3
2025
190
0.120
 Why?
Receptors, Androgen
1
2017
149
0.120
 Why?
Genital Neoplasms, Female
1
2017
99
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
Gene Expression
2
2016
1478
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
979
0.110
 Why?
Neoplasms, Second Primary
1
2016
102
0.110
 Why?
Ovary
1
2017
234
0.110
 Why?
Single-Cell Analysis
1
2019
361
0.110
 Why?
Combined Modality Therapy
2
2019
1270
0.110
 Why?
Ribosomal Proteins
1
2015
93
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2017
440
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
DNA Primers
1
2016
505
0.110
 Why?
Cell Movement
4
2026
961
0.110
 Why?
Isoquinolines
2
2025
43
0.110
 Why?
Risk Reduction Behavior
1
2016
217
0.110
 Why?
Azetidines
2
2025
45
0.110
 Why?
Hodgkin Disease
1
2016
172
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
STAT5 Transcription Factor
1
2014
50
0.110
 Why?
Reactive Oxygen Species
1
2017
611
0.110
 Why?
Azepines
1
2015
105
0.100
 Why?
Fibroblasts
1
2020
1027
0.100
 Why?
Pyrazoles
1
2018
517
0.100
 Why?
Odds Ratio
1
2017
1083
0.100
 Why?
Receptors, Steroid
1
2014
42
0.100
 Why?
Microscopy, Atomic Force
1
2014
128
0.100
 Why?
Apoptosis
4
2017
2443
0.100
 Why?
Peptides
1
2020
998
0.100
 Why?
Software
2
2019
680
0.100
 Why?
Clinical Decision-Making
1
2017
364
0.100
 Why?
Quinazolines
2
2025
266
0.090
 Why?
CD24 Antigen
1
2012
18
0.090
 Why?
DNA-Binding Proteins
2
2015
1482
0.090
 Why?
Sensitivity and Specificity
2
2016
2000
0.090
 Why?
RNA Interference
1
2014
475
0.090
 Why?
Retinoids
1
2012
36
0.090
 Why?
Anthracyclines
2
2023
49
0.090
 Why?
Opioid-Related Disorders
1
2021
605
0.090
 Why?
Disease Models, Animal
4
2017
4568
0.090
 Why?
Taxoids
2
2023
114
0.090
 Why?
Cell Differentiation
4
2004
2050
0.090
 Why?
Comorbidity
1
2017
1662
0.090
 Why?
Clinical Trials as Topic
1
2017
1062
0.090
 Why?
Genome, Human
1
2014
422
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
174
0.090
 Why?
Drug Discovery
1
2012
153
0.080
 Why?
Small Molecule Libraries
1
2012
111
0.080
 Why?
Rats
5
2017
5585
0.080
 Why?
Tumor Burden
1
2012
325
0.080
 Why?
United States
4
2023
16123
0.080
 Why?
Male
8
2018
73003
0.080
 Why?
Logistic Models
1
2016
2139
0.080
 Why?
Mitochondria
1
2017
992
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
751
0.080
 Why?
Estrogen Antagonists
1
2010
37
0.080
 Why?
Dendritic Cells
2
2004
500
0.080
 Why?
Nuclear Proteins
1
2015
740
0.080
 Why?
Time Factors
3
2020
7133
0.080
 Why?
Lung Neoplasms
1
2023
2667
0.070
 Why?
Transforming Growth Factor beta
1
2012
474
0.070
 Why?
BRCA2 Protein
1
2009
68
0.070
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.070
 Why?
Cell Culture Techniques
2
2020
375
0.070
 Why?
Administration, Oral
2
2024
867
0.070
 Why?
Thrombophilia
1
2009
89
0.070
 Why?
Receptors, CXCR4
2
2006
91
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1372
0.070
 Why?
Cells, Cultured
3
2006
4151
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1217
0.070
 Why?
Stem Cell Transplantation
3
2004
189
0.060
 Why?
Proteoglycans
2
2006
112
0.060
 Why?
Genetic Predisposition to Disease
1
2016
2399
0.060
 Why?
Radiotherapy, Adjuvant
2
2018
222
0.060
 Why?
Immunohistochemistry
2
2017
1723
0.060
 Why?
Rats, Sprague-Dawley
2
2002
2525
0.060
 Why?
Aurora Kinase A
2
2018
61
0.060
 Why?
Algorithms
1
2014
1850
0.060
 Why?
Risk Factors
2
2020
10917
0.060
 Why?
Drug Delivery Systems
1
2010
381
0.060
 Why?
Proof of Concept Study
1
2026
89
0.060
 Why?
Biopsy
2
2020
1082
0.060
 Why?
Severity of Illness Index
1
2014
2933
0.060
 Why?
Transcription Factor TFIIIB
1
2025
5
0.060
 Why?
TATA-Binding Protein Associated Factors
1
2025
21
0.060
 Why?
Nervous System
1
2006
69
0.060
 Why?
Rats, Inbred F344
2
2003
268
0.060
 Why?
Mass Spectrometry
2
2020
731
0.060
 Why?
Cyclin-Dependent Kinase 4
1
2025
53
0.060
 Why?
Cyclin-Dependent Kinase 6
1
2025
49
0.060
 Why?
Neoplasm Transplantation
2
2016
246
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2770
0.050
 Why?
Infant, Premature, Diseases
1
2006
113
0.050
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.050
 Why?
Aggrecans
1
2004
15
0.050
 Why?
Purines
1
2025
187
0.050
 Why?
Lectins, C-Type
1
2004
59
0.050
 Why?
Cyclophosphamide
2
2018
272
0.050
 Why?
Maximum Tolerated Dose
1
2024
211
0.050
 Why?
Cell Line
2
2014
2823
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
8
0.050
 Why?
Mastectomy, Segmental
2
2017
107
0.050
 Why?
Adipose Tissue
2
2018
645
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Bridged-Ring Compounds
1
2023
31
0.050
 Why?
Follow-Up Studies
2
2025
5428
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
8
0.050
 Why?
Aromatase
1
2023
37
0.050
 Why?
Glioblastoma
2
2006
354
0.050
 Why?
Camptothecin
1
2023
138
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
58
0.050
 Why?
Edema
1
2023
125
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
9
0.050
 Why?
Pyramidal Tracts
1
2002
30
0.050
 Why?
Sciatic Nerve
1
2002
63
0.050
 Why?
Neurites
1
2002
50
0.050
 Why?
Mice, Inbred C57BL
5
2004
5992
0.050
 Why?
Vimentin
1
2022
54
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.040
 Why?
Gonadotropin-Releasing Hormone
1
2024
217
0.040
 Why?
Interleukin-12
1
2002
115
0.040
 Why?
Phenotype
1
2010
3170
0.040
 Why?
Blotting, Western
1
2004
1184
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
106
0.040
 Why?
Frontal Lobe
1
2002
160
0.040
 Why?
Oligonucleotides, Antisense
1
2002
120
0.040
 Why?
Fibroblast Growth Factors
1
2002
188
0.040
 Why?
Mice, Inbred BALB C
1
2004
1261
0.040
 Why?
Ependymoma
1
2003
176
0.040
 Why?
Protein-Lysine 6-Oxidase
1
2020
14
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Cerebral Cortex
1
2004
474
0.040
 Why?
TOR Serine-Threonine Kinases
1
2024
456
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Nucleosomes
1
2022
163
0.040
 Why?
Weight Loss
1
2026
859
0.040
 Why?
Nervous System Diseases
1
2003
286
0.040
 Why?
Neoplasms
1
2015
2913
0.040
 Why?
Animals, Newborn
1
2002
896
0.040
 Why?
Adherens Junctions
1
2020
24
0.040
 Why?
Membrane Glycoproteins
1
2002
499
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
2028
0.040
 Why?
Gene Knockout Techniques
1
2020
119
0.040
 Why?
Protein Interaction Mapping
1
2020
105
0.040
 Why?
Patient Acceptance of Health Care
1
2026
883
0.040
 Why?
Interferon-gamma
1
2002
784
0.040
 Why?
Kaplan-Meier Estimate
1
2021
971
0.040
 Why?
Mice, Nude
2
2015
680
0.040
 Why?
DNA, Complementary
1
2019
273
0.030
 Why?
beta-Galactosidase
3
2002
76
0.030
 Why?
Loss of Function Mutation
1
2018
45
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Cadherins
1
2020
200
0.030
 Why?
Nausea
1
2018
112
0.030
 Why?
Immunotherapy
1
2003
667
0.030
 Why?
Wnt Signaling Pathway
1
2020
212
0.030
 Why?
Breast
1
2018
156
0.030
 Why?
Phenylthiohydantoin
1
2017
44
0.030
 Why?
Diarrhea
1
2018
193
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
62
0.030
 Why?
Area Under Curve
1
2017
332
0.030
 Why?
Mastectomy
1
2018
185
0.030
 Why?
Ovariectomy
1
2017
166
0.030
 Why?
Antigens, CD
1
2020
558
0.030
 Why?
Steroids
1
2017
160
0.030
 Why?
Benzamides
1
2017
226
0.030
 Why?
Cell Membrane
1
2020
709
0.030
 Why?
Nitriles
1
2017
211
0.030
 Why?
Fatigue
1
2018
365
0.030
 Why?
Flow Cytometry
2
2012
1165
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
187
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
67
0.030
 Why?
Chromatography, Liquid
1
2017
450
0.030
 Why?
Tumor Protein p73
1
2015
18
0.030
 Why?
Postmenopause
1
2017
394
0.030
 Why?
Gene Knockdown Techniques
1
2015
334
0.030
 Why?
Molecular Targeted Therapy
1
2017
440
0.030
 Why?
Transcription Factors
1
2002
1736
0.030
 Why?
Weight Gain
1
2018
561
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Jagged-1 Protein
1
2014
22
0.030
 Why?
Wnt-5a Protein
1
2014
25
0.030
 Why?
Argonaute Proteins
1
2014
32
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
56
0.030
 Why?
Testosterone
1
2017
416
0.020
 Why?
Cell Transformation, Neoplastic
1
2015
337
0.020
 Why?
Cellular Microenvironment
1
2014
93
0.020
 Why?
Gene Expression Regulation
1
2022
2601
0.020
 Why?
Wnt Proteins
1
2014
133
0.020
 Why?
Interleukin-6
1
2017
779
0.020
 Why?
Guideline Adherence
1
2017
587
0.020
 Why?
Socioeconomic Factors
1
2017
1327
0.020
 Why?
Acitretin
1
2012
3
0.020
 Why?
Miconazole
1
2012
5
0.020
 Why?
Calcium-Binding Proteins
1
2014
221
0.020
 Why?
Isotretinoin
1
2012
26
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
376
0.020
 Why?
Luciferases
1
2012
154
0.020
 Why?
Genes, Reporter
1
2012
277
0.020
 Why?
Tretinoin
1
2012
125
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
552
0.020
 Why?
Biomarkers
2
2017
4302
0.020
 Why?
Risk Assessment
1
2020
3752
0.020
 Why?
Green Fluorescent Proteins
1
2012
407
0.020
 Why?
Proto-Oncogene Proteins
1
2014
625
0.020
 Why?
Diet
1
2018
1278
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3915
0.020
 Why?
Base Sequence
1
2014
2171
0.020
 Why?
Colorado
1
2020
4556
0.020
 Why?
HEK293 Cells
1
2012
741
0.020
 Why?
Age Factors
1
2017
3346
0.020
 Why?
Hypertension
1
2018
1276
0.020
 Why?
Molecular Sequence Data
1
2014
2883
0.020
 Why?
Pregnancy Trimester, Second
1
2009
84
0.020
 Why?
Practice Guidelines as Topic
1
2017
1582
0.020
 Why?
Pregnancy Trimester, First
1
2009
139
0.020
 Why?
Lymph Node Excision
1
2009
173
0.020
 Why?
Transplantation, Heterologous
1
2008
170
0.020
 Why?
Endothelial Cells
1
2014
877
0.020
 Why?
Membrane Proteins
1
2014
1166
0.020
 Why?
Neoplasms, Experimental
1
2008
167
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
923
0.010
 Why?
Chemokines, CXC
1
2006
68
0.010
 Why?
Nestin
1
2006
19
0.010
 Why?
Laminin
1
2006
72
0.010
 Why?
Intermediate Filament Proteins
1
2006
57
0.010
 Why?
CD4-Positive T-Lymphocytes
2
2002
1146
0.010
 Why?
Chemokine CXCL12
1
2006
86
0.010
 Why?
Infant, Newborn
2
2009
6464
0.010
 Why?
Lasers
1
2006
127
0.010
 Why?
Glial Fibrillary Acidic Protein
1
2006
122
0.010
 Why?
Drug Combinations
1
2006
396
0.010
 Why?
Adolescent
1
2024
22573
0.010
 Why?
Culture Media, Conditioned
1
2004
112
0.010
 Why?
RNA, Small Interfering
1
2006
638
0.010
 Why?
Injections, Intralesional
1
2003
35
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
54
0.010
 Why?
3T3 Cells
1
2002
156
0.010
 Why?
Random Allocation
1
2003
365
0.010
 Why?
Nerve Tissue Proteins
1
2006
592
0.010
 Why?
Models, Neurological
1
2004
250
0.010
 Why?
Adenoviridae
1
2002
199
0.010
 Why?
Reference Values
1
2003
798
0.010
 Why?
Infant, Premature
1
2006
620
0.010
 Why?
Genetic Vectors
1
2002
335
0.010
 Why?
Transfection
1
2002
927
0.010
 Why?
Oligodendroglia
1
2002
190
0.010
 Why?
Recombinant Fusion Proteins
1
2002
666
0.010
 Why?
Case-Control Studies
1
2006
3634
0.010
 Why?
Survival Rate
1
2003
2094
0.010
 Why?
Pregnancy
1
2009
7215
0.010
 Why?
Vaccination
1
2003
1428
0.010
 Why?
Prospective Studies
1
2006
8075
0.010
 Why?
Infant
1
2006
10090
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (428) concept(s)
_
Co-Authors Expand Description
See all (75) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)